Hofseth BioCare ASA reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was NOK 13.66 million compared to NOK 7.3 million a year ago. Revenue was NOK 13.66 million compared to NOK 7.58 million a year ago. Net loss was NOK 37.79 million compared to NOK 32.86 million a year ago. Basic loss per share from continuing operations was NOK 0.11 compared to NOK 0.1 a year ago. Diluted loss per share from continuing operations was NOK 0.11 compared to NOK 0.1 a year ago. For the nine months, sales was NOK 61.43 million compared to NOK 37.51 million a year ago. Revenue was NOK 61.54 million compared to NOK 46.2 million a year ago. Net loss was NOK 89.27 million compared to NOK 71.02 million a year ago. Basic loss per share from continuing operations was NOK 0.25 compared to NOK 0.22 a year ago. Diluted loss per share from continuing operations was NOK 0.25 compared to NOK 0.22 a year ago.